| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.049 | 0.4 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.062 | 0.4 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.4 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |